Pediatric cancer specialist speaks Nov. 10

Dr. Michael Jensen of Seattle Children's will present the next Clinical Research Division Immunotherapy Seminar Series lecture Thursday, Nov. 10, 2-3 p.m. in Pelton Auditorium.

Jensen, director of the hospital’s Center for Childhood Cancer Research and professor of pediatrics in the University of Washington's Division of Pediatric Hematology/Oncology, will discuss "T Lymphocyte Engineering for Cancer Adoptive Therapy."
 
The presentation will highlight:

• Design and development of chimeric antigen and cytokine receptors
• Development of human selection/ suicide transgenes
• Strategies to improve function in the tumor bearing host
• Considerations for T-cell subset selection for clinical applications

Former Hutchinson Center fellow

Jensen joined Seattle Children's in 2010 after spending 13 years at City of Hope, where he was director of Pediatric Cancer Program and co-leader of the Cancer Immunotherapeutics and Tumor Immunology department. In addition to authoring more than 60 research papers, Jensen is the recipient of two Young Investigator Awards and more than $2 million in research funding from the National Institutes of Health. At City of Hope he conducted the first Food and Drug Administration authorized trial of T-cell therapies for children with recurrent neuroblastoma. 

Jensen studied at the University of Pennsylvania School of Medicine and completed a fellowship in pediatric hematology-oncology at the UW and the Hutchinson Center.

For more information on the CRD seminar series, send an email to immunotherapy@fhcrc.org. Disability accommodations are available upon request. Please contact the ESC help desk at escmail@fhcrc.org or (206) 667-4700.